Business
As of Jan. 1, up to 6M patients can look forward to significantly reduced costs and a simpler application process
Hi, what are you looking for?
Mugglehead Investment Magazine
Medical and Pharmaceutical
International
It's unclear what will happen with the proposed regulatory framework
International
Most licences will be issued without a fixed end date
Business
The Canadian firm has partnered with a subsidiary of US pharmaceutical firm Merger Group
Canada
Some study participants stopped using cannabis out of fear of potential harm to the fetus, while others stopped because of social stigma, guilt and...
Business
Initial deliveries have been made to local pharmacies with planned shipments for Germany and the UK
Business
Olorinab is a CB2 receptor agonist in a Phase 2 trial for IBS
Business
The firm will celebrate by ringing the opening bell at the stock exchange on Thursday
Health and Safety
Compared to non-consumers, people who used cannabis 20 days a month were more likely to experience both extremes of sleep duration
Business
The new facility will feature the firm's ketamine-assisted therapy program, as well as a range of health and lifestyle services
